Novo Nordisk, headquartered in Copenhagen, has seen its shares surge by more than 6 per cent after unveiling promising results from a late-stage clinical trial of its new anti-obesity tablet.
All posts tagged in Healthcare Innovation
24Articles
New data from NHS England reveals that specialist artificial intelligence (AI) technology is transforming outcomes for stroke patients, tripling the likelihood of making a full recovery in some cases. Since
Alzheimers patients can extend cognitive health for years with breakthrough drugs ||| Groundbreaking trial results have revealed that radical new treatments can effectively stall the progression of Alzheimer’s disease for
In a landmark transaction, US pharmaceutical behemoth Merck has secured the acquisition of London-based Verona Pharma for approximately $10 billion, marking a significant milestone in the biotech sector. The deal
The British government is poised to implement stringent restrictions on alcohol advertising as part of its comprehensive ten-year NHS strategy. Health Secretary Wes Streeting’s department, recently bolstered by a £30
In a significant move towards modernising cancer diagnostics, the NHS has announced a £2.4 million investment in groundbreaking blood test technology capable of detecting 12 different types of cancer. The
The American pharmaceutical giant Pfizer has discontinued the development of its experimental weight-loss pill following safety concerns, marking a significant setback in its pursuit of the lucrative anti-obesity market, estimated
A groundbreaking development in pharmaceutical research has unveiled gepotidacin as the first new antibiotic treatment for gonorrhoea in three decades, presenting significant market implications for healthcare investors. The innovation addresses
Revolutionary NHS Cancer Vaccine Trial Signals Fresh Hope for Investment in UK Healthcare Innovation
The National Health Service has unveiled a groundbreaking initiative, offering accelerated access to a pioneering cancer vaccine trial. This strategic move demonstrates the UK’s commitment to maintaining its position at
In a groundbreaking initiative aimed at addressing a multitude of social and health-related issues, an ambitious scheme is set to deploy an army of health workers door-to-door across various regions
Oxford Medical Simulation, a UK-based virtual reality (VR) training company, has shifted its primary focus to the United States, citing bureaucratic obstacles within the NHS as a major hindrance to
Market observers and healthcare analysts are closely monitoring a groundbreaking development in the oncology sector, where a pioneering immunotherapy treatment has demonstrated remarkable longevity in its effectiveness. A patient treated
A groundbreaking clinical trial at University College London (UCL) is poising to transform the landscape of alcohol misuse treatment through the utilisation of dimethyltryptamine (DMT), a potent psychedelic compound. The
British healthcare technology firm Cera has secured a landmark $150 million funding round, propelling the company to coveted unicorn status with a valuation exceeding $1 billion. The fundraising effort, combining
The British government is weighing a groundbreaking initiative that would permit private enterprises to monetise NHS patient data, marking a significant shift in healthcare data management. Labour leader Keir Starmer
British pharmaceutical giant GSK has struck a significant deal worth up to $1.15 billion to acquire IDRx, a Massachusetts-based biopharmaceutical company, strengthening its position in the oncology sector. The FTSE
- 1
- 2
